IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that, as part of its efforts to strengthen its organizational framework for the mid- to long-term advancement of new treatment development and clinical advancement, it has appointed Dr. Youn Seongjae, Representative Director of the Korean aesthetic dermatology group Leaders Dermatology Clinic, as an Advisor. This appointment aims to go beyond the one-time introduction of advanced overseas aesthetic medical techniques, and instead to embed such knowledge across the Group as a sustainable framework that enhances both the quality and reproducibility of medical care.
Dr. Youn Seongjae, who has joined SBC Medical as an Advisor, has extensive experience in South Korea, a global leader in aesthetic medicine that has produced numerous internationally recognized dermatologic treatments. Over many years, he has been engaged in advancing medical technologies and educating the next generation of physicians. Leaders Dermatology Clinic, where Dr. Youn serves as Representative Director, was founded in 2001 with the philosophy of “Dignified Beauty” and has since expanded to 12 locations domestically and internationally. The group promotes an integrated approach that combines academic research, physician education, and advanced clinical practice.
The clinic group is characterized by a physician structure centered on board-certified dermatologists, primarily graduates of Seoul National University College of Medicine, one of Korea’s leading medical schools.Through lectures and educational activities at international conferences and seminars, the group has worked to improve the quality of medical services and establish systematic clinical frameworks, consistently pursuing the standardization and advancement of medical care as an organization. These initiatives and medical systems demonstrate strong alignment with SBC Medical’s philosophy of prioritizing medical quality and reproducibility while enhancing medical value across the Group.
Dr. Youn Seongjae’s knowledge and practical experience are expected to provide important insights into SBC Medical’s treatment development initiatives and medical personnel training. Going forward, SBC Medical will continue to incorporate the latest clinical insights and treatment trends from Korean aesthetic medicine. Through technical guidance, new treatment planning and development, and academically grounded quality enhancement initiatives, the Company aims to further strengthen its medical platform across the Group.
Career Highlights and Professional Affiliations
●Career
・Graduated from Seoul National University College of Medicine
・Dermatology department at Samsung Medical Center (board-certified)
・Chairman of the Academic Committee, Korean Society of Anti-Aging Dermatology
・Chief Academic Director, Korean Society of Anti-Aging Dermatology
●Awards
Best Speaker: 17th Minimal Invasive Plastic Surgery Symposium
Best Lecture: 18th Korean Dermatologists Symposium
●Professional Society
・Member of Korean Dermatological Association
・The vice president, Korean Society for Anti-Aging Dermatology
・The chairman of the academic committe , Korean Society for Anti-Aging Dermatology
・Administrator, Academic affairs, Korean Society for Anti-Aging Dermatology
・Administrator, Educational affairs, Korean Society for Anti-Aging Dermatology
・Administrator, Public Relations, Korean Society for Dermatologic Surgery
・Assistant Administrator, Publication affairs, the association of Korean dermatologists
Leaders Dermatology Clinic
Founded in 2001 by board-certified dermatologists who graduated from Seoul National University College of Medicine, Leaders Dermatology Clinic has grown into a leading dermatology clinic group with more than 20 board-certified dermatologists and approximately 150 staff members, operating 12 locations in Korea and overseas.The physicians actively engage in academic activities, including lectures at domestic and international conferences and seminars, continually striving to advance their clinical expertise and medical knowledge. With the goal of achieving the highest levels of patient satisfaction, the group is committed to providing high-quality medical services through a well-organized clinical system developed in close collaboration with its staff.
Official Web Site：https://m.leaders-eng.com/
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com/
For more insights and updates from SBC Holdings, follow us on LinkedIn
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," "targets" or "hopes" or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.
Contacts
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of IR Department E-mail: ir@sbc-holdings.com
Akiko Wakiyama / CPRO E-mail: pr@sbc.or.jp
ICR LLC (US Time)
Bill Zima / Managing Partner Email: bill.zima@icrinc.com